Newsletter | November 18, 2026

11.18.26 -- OPCU: Preparing Fill-Finish Operations For Scale And Commercial Supply

 

 

Fill-finish is one of the final steps before a drug product reaches patients, but teams often need to make the decisions that shape its success much earlier. As programs progress toward larger clinical studies and commercialization, aseptic processing requirements, technology transfer, equipment compatibility, capacity, and supply planning can introduce new risks to timelines and product quality.

 

A well-planned fill-finish strategy can help sponsors anticipate these challenges while creating a smoother path toward scale and commercial supply. In this edition of the Outsourced Pharma Capabilities Update (OPCU), explore how CDMOs are approaching sterile fill-finish across different stages of development, with perspectives on managing operational complexity, preparing for technology transfer, and building greater flexibility into future production. Watch the presentations below for practical considerations that can help strengthen your fill-finish strategy.

 

Recent Sessions Available On-Demand                                 
 AI Drug Manufacturing & Viral Vectors – October 2026                             
 mRNA & Packaging, Labeling & Logistics – October 2026                             
 Fill/Finish – October 2026                             
 ADC – October 2026                        

 

Upcoming OPCU Topics & Times               
 Enabling ADC Success | 12/1/2026, PM Session                               
 Mastering Aseptic Fill-Finish | 12/1/2026, PM Session                          

 

Access more on-demand OPCU recordings and upcoming sessions here.

FILL/FINISH

Thermo Fisher Scientific

Learn how to balance technical, regulatory, and supply chain considerations while avoiding costly late-stage changes and preparing for successful technology transfer, scale-up, and commercialization.

Request Information

Thermo Fisher Scientific

Lonza

Bastian Klöfer, Director of Commercial Development, Drug Product Services, explores Lonza's end-to-end biologics network, spanning drug substance, drug product development, manufacturing, analytics and regulatory support.

Request Information

Lonza

Simtra Biopharma Solutions

Explore new sterile manufacturing capacity for pre-filled syringes, lyophilized vials, and potent therapies, supporting flexibility, scale, and supply resilience.

Request Information

Simtra BioPharma Solutions

PCI Pharma Services

PCI integrates scalable manufacturing, packaging, device assembly, and global regulatory expertise to streamline tech transfer and strengthen supply chain resilience.

Request Information

PCI Pharma Services

Alcami

Discover critical considerations for sterile fill-finish, including manufacturability, scale-up, contamination control, and the path from clinical to commercial supply.

Request Information

Alcami